focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Hi Everyone,
Can somebody please confirm whether Aidan Earley has actually passed away?
I cannot find conclusive proof of this.
I almost invested the day before this was suspended because it seemed like a no-brainer, it was that good!
Obviously, fraudulently too good to be true (or we suspect now!).
This is an awful fraud and I sincerely hope that all here have not had serious losses affecting their health and personal lives. I really hope there will be some mechanism by which shareholders can be compensated IF it transpires that their investments were made on disinformation.
THIS IS NOT YOUR FAULT!
If you invested on the basis of what you thought was official information, that was a fraudulent lie, that's not your fault! You should be fully reimbursed.
We shall see.
Whatever happens, have a peaceful christmas, new year and may the new year bring something good at the end of this journey.
In reality yes but this whole thing stinks and I wouldn't want to be involved now.
I expect the target price to come down to 200p or something, but lets be honest, you'll all be chuffed with that anyway, so who cares?
Undervalued here! Looks good for a recovery to £10!
Load up and hold for gold!
At this point, flava is topping up with so many shares that they'll have to make a bid for the company.
Anyway, here we are folks.
Top up time it is.
Strong buy at these levels for a likely good recovery on third-party backer news.
Wait for the broker coverage too!
There will be 3x the number of shares in issue at 11p!
That's a huge dilution!
Worse than I'd anticipated.
However, do not be alarmed there's massive value here.
If you decide to trade it that might be sensible (can't advise), but good luck whatever you decide.
I honestly think this is a game of see how close to 11p you can buy in now and you'll make good money!
It's a shame I don't have any!
For the record, I wouldn't be worried if I was in at a higher price, I think this will be transformational and return to 50-60p in the not too distant future. The scale of dilution has reduced me down from a target of 160p, that's unrealistic for now.
Display is certainly dead for Nanoco. They gave it to Samsung.
Wait for the placing
Top up after the placing
Sells showing as buys, delayed sells. The usual explanation.
Sorry yes, you're right they will be supplying Apple with the device with Nano tech.
It's almost certainly Nanoco because all communications have aligned so far.
When AR Glasses really take off is another issue. It all sounds gimmicky for me, so the risk is it's not the big inflection point Nanoco holders have been hoping for.
Popeye62 as an objective investor I make up my mind based on the best information available.
The reason I said strong sell at 12p was because there was no new information on the market to suggest there was any likely development of the heart valve and cash was severely depleted. The information surrounding the pursuit of a partner is a game-changer, hence I changed to buy again.
However, it's now in freefall with unanswered questions about the funding of the overall business.
It makes sense that it will settle at previous support for this reason, unless there's a new announcement regarding the new partner and a favourable funding arrangement, which could also happen.
People often say I have agenda, I don't.
It's a fast-changing scenario and people need to keep up.
Long-term is a no-brainer strong buy for me, but this will go lower first.
STM are very likely to be supplying Apple with the dots from Nanoco. I have little doubt about that.
As for the share buy back.
The suggested terms were clear.
10p - 12p per share, which means a massive return for people who got in at these levels.
A not so massive return for long-term holders.
They definitely need funds. When companies pitch a placing, they have to do it at an attractive price.
Nobody is going to buy substantial quantities on a spike up to 45p.
They would look at the share price chart and be too nervous.
15p is a very attractive price to enter.
Of course it's possible that funding will be part of whatever deal they make for heart valve licensing.
This is too cheap, but it will most likely get a bit cheaper before it rises again in my opinion
Hi everyone, before the recent surge from 20p to 60p and back, I didn't invest due to inevitable funding requirements.
There maybe more to come down the line, but this gets us over the line for now.
I don't invest anymore, but enjoy a fantasy portfolio.
SED is a strong buy at this point. Ride it up again and sell out!
It looks like this is tumbling down to around 15p. Then there's the placing!
Fundamentalanalysis chipping in with fundamentally wrong analysis.
The heart valve project will not be funded via dilution.
The business can be and most likely will be.
A placing is extremely likely, but they might put the announcement in with the wider funding news and the market will go bananas anyway OR RUA will be taken over as I keep saying. This is also very likely in my opinion.
The share price is falling due to the obvious short-term risk of imminent funding.
It's not as straight-forward as saying wait for the placing then buy this time though because the funding could include a massive inflection point for the company. If you bought at 30p+ and the share price falls to 15p again, don't worry. It's not going to be a problem in a few years time. Look at the historic share price and see how it was 160p on a hint of where the company is now very close to.
Disappointing update, dilution imminent!
This will fall substantially from here, however the long-term picture is very promising.
Great post flava, other than a third-party JV or takeover, the time-scale for commercialization is three years.
That's what deters the quick buck traders.